drugset
drugset / Trial / NCT02462122

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

NCT02462122 ↗

Phase 3 Completed 215 enrolled Bausch Health Americas, Inc. Dow Pharmaceutical Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis

Timeline

Start
2015-08-19
Primary completion
2016-11-09
Completion
2016-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-118 Unknown — —

Indications

psoriasis